October 1, 2019

First Baby Tested Via Parent Project Muscular Dystrophy’s Newborn Screening Pilot

Today, our community’s collective efforts have led to an incredible milestone for PPMD’s Duchenne Newborn Screening Pilot in New York State. Today, the first babies are being SCREENED for Duchenne. This is a significant milestone…

Learn More

September 6, 2019

Watch Live: Duchenne Platform Trial Community Meeting

Parent Project Muscular Dystrophy (PPMD) will co-host the first Duchenne Muscular Dystrophy Platform Trial Community Meeting, along with collaborators I-ACT for Children and Critical Path Institute (C-Path) on September 9, 2019 at the Sheraton Silver…

Learn More

August 16, 2019

ICER Releases Report; PPMD Issues Open Letter to Payers

Last night, the Institute for Clinical and Economic Review (ICER) released their final report assessing three Duchenne products: Emflaza, EXONDYS 51, and golodirsen. This report integrates all public comments, stakeholder engagement, and the Roundtable proceedings…

Learn More

July 25, 2019

Newborn Screening Saves Lives Reauthorization Act Passes in House of Representatives

We are thrilled to share that last night the House of Representatives passed HR 2507 – the Newborn Screening Saves Lives Reauthorization Act by voice vote! PPMD has been proud to be a part of…

Learn More

July 24, 2019

ICER Roundtable – What Does It Mean?

In December 2018, the Institute for Clinical and Economic Review (ICER) announced that it would be conducting an assessment of three Duchenne products over the next seven months. The ICER assessment is culminating in a…

Learn More

July 12, 2019

2019 #PPMDConference Presentations

2019 PPMD Annual Conference Resources & Recordings JUNE 27 – JUNE 29, 2019 | Orlando, Florida Thank you doesn’t begin to express our gratitude to everyone who participated in our 25th Annual Conference in Orlando,…

Learn More

June 24, 2019

PPMD: Your Strength, Your Family

PPMD: Your Strength, Your Family I had no intention of being part of the Duchenne community this long. When we started PPMD in 1994, I naively thought we would have a cure and I would…

Learn More

June 17, 2019

Sharing Our Patient Experience

PPMD has been an active voice in rare disease to ensure that our community’s experience of Duchenne is collected meaningfully and integrated fully into all aspects of the drug development life cycle. Today we participated…

Learn More

June 3, 2019

PPMD Contributes to National Report on Caregiver Roles in Medical Product Development

For the last few years, PPMD has been working in partnership with the National Alliance for Caregiving, which has included the participation of PPMD’s Annie Kennedy on the planning committee of a national summit that…

Learn More

May 16, 2019

PPMD Signs on to Defense Health Research Letters

PPMD is proud to serve as a member of the Defense Health Research Consortium. Last week, letters were sent to both houses of Congress asking for their continued support for the critical and highly successful…

Learn More